StockData
Surgery Partners, Inc. logo

Surgery Partners, Inc. (SGRY) stock

SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/308% above fair value
$26.95+0.37 (+1.39%)

Close on Nov 13, 2026Market cap $3.53BP/E –Yield –

Surgery Partners cash

Cash and short-term investments held at the end of each period.

Surgery Partners's cash was $354.50M at Sep 30, 2026. For fiscal 2025 it was $239.90M, down 11.0% from the year before. Over ten years it grew 15.3% a year on average. The highest annual figure on record is $389.90M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$239.90M-11.0%
FY2024Dec 31, 2024$269.50M+37.6%
FY2023Dec 31, 2023$195.90M-30.8%
FY2022Dec 31, 2022$282.90M-27.4%
FY2021Dec 31, 2021$389.90M+22.5%
FY2020Dec 31, 2020$318.20M+242.2%
FY2019Dec 31, 2019$93.00M-49.6%
FY2018Dec 31, 2018$184.60M+5.4%
FY2017Dec 31, 2017$175.20M+150.3%
FY2016Dec 31, 2016$70.00M+20.8%
FY2015Dec 31, 2015$57.93M-22.7%
FY2014Dec 31, 2014$74.92M+475.2%
FY2013Dec 31, 2013$13.03M+149.0%
FY2012Dec 31, 2012$5.23M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$354.50M+74.3%
Q2 FY2026Jun 30, 2026$216.70M-13.4%
Q1 FY2026Mar 31, 2026$182.30M-20.5%
Q4 FY2025Dec 31, 2025$239.90M-11.0%
Q3 FY2025Sep 30, 2025$203.40M-8.3%
Q2 FY2025Jun 30, 2025$250.10M+17.1%
Q1 FY2025Mar 31, 2025$229.30M+23.8%
Q4 FY2024Dec 31, 2024$269.50M+37.6%
Q3 FY2024Sep 30, 2024$221.80M-6.0%
Q2 FY2024Jun 30, 2024$213.50M+20.3%
Q1 FY2024Mar 31, 2024$185.20M-24.6%
Q4 FY2023Dec 31, 2023$195.90M-30.8%
Q3 FY2023Sep 30, 2023$236.00M+52.5%
Q2 FY2023Jun 30, 2023$177.40M-22.0%
Q1 FY2023Mar 31, 2023$245.50M-35.2%
Q4 FY2022Dec 31, 2022$282.90M-27.4%
Q3 FY2022Sep 30, 2022$154.80M-53.1%
Q2 FY2022Jun 30, 2022$227.40M-51.1%
Q1 FY2022Mar 31, 2022$378.90M-30.1%
Q4 FY2021Dec 31, 2021$389.90M+22.5%
Q3 FY2021Sep 30, 2021$330.40M-26.6%
Q2 FY2021Jun 30, 2021$464.80M+42.3%
Q1 FY2021Mar 31, 2021$541.90M+178.0%
Q4 FY2020Dec 31, 2020$318.20M+242.2%
Q3 FY2020Sep 30, 2020$450.30M+303.5%
Q2 FY2020Jun 30, 2020$326.60M+177.5%
Q1 FY2020Mar 31, 2020$194.90M+36.5%
Q4 FY2019Dec 31, 2019$93.00M-49.6%
Q3 FY2019Sep 30, 2019$111.60M+40.6%
Q2 FY2019Jun 30, 2019$117.70M+22.1%
Q1 FY2019Mar 31, 2019$142.80M+26.3%
Q4 FY2018Dec 31, 2018$184.60M+5.4%
Q3 FY2018Sep 30, 2018$79.40M-60.3%
Q2 FY2018Jun 30, 2018$96.40M+69.0%
Q1 FY2018Mar 31, 2018$113.10M+102.1%
Q4 FY2017Dec 31, 2017$175.20M+150.3%
Q3 FY2017Sep 30, 2017$200.02M–
Q2 FY2017Jun 30, 2017$57.03M–
Q1 FY2017Mar 31, 2017$55.97M–
Q4 FY2016Dec 31, 2016$70.00M–

More Surgery Partners figures

See a number that looks wrong?